Genedata Announces AstraZeneca Standardizes on Genedata Screener as its Global Screening Platform

New five-year license agreement extends AstraZeneca-Genedata partnership; Genedata Screener now AstraZeneca’s corporate platform for expediting drug discovery   From Genedata – Basel, Switzerland  – November 20, 2015 – Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced it has signed a five-year license agreement with AstraZeneca (LON:AZN). … Read more…

A New High Content Screen for Repairing Hearing Loss

Translating the intricacies of sensory regeneration to an in vitro assay is still a work in progress.  In the case of hearing or the auditory pathway few models have been developed that are surrogate for hearing loss save in vivo models which are impractical for compound screening.  Dr. Donna Whitlon at Northwestern University published a … Read more…